Delivery Order SPE2DB20D1110-SPE2DB25FK37K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,731.88 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,835.76 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of October 29, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and represents a direct purchase of pharmaceutical inventory to support federal medical supply needs. The place of performance is AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,820.04 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of November 14, 2025, issued one day prior on November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,833.37 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with a completion deadline of December 2, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a $14,891.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical product requisition under the agency's medical supply procurement operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,386.62 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition to the most...
- The Defense Logistics Agency awarded a delivery order valued at $4,233.27 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, non-set-aside contract utilizes firm fixed price terms with an ultimate completion date of August 6, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a ceiling value of $10,727.51 and an ultimate completion date of November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,820.04 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, utilizes no set-aside designation and was competitively awarded. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.14 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was awarded competitively with no set-aside designation. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK37KDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,848.74 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was awarded through open competition among qualified vendors. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, positioning it as a key supplier for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 8/28/25 |